Focus on French HealthTech’s ecosystem : Panorama France HealthTech 2026 ‘s review: a mature, innovative and resilient sector facing a more demanding environment
The French HealthTech sector remains robust with nearly 2,800 companies, despite a challenging economic environment. The industry is characterized by its strong focus on R&D and innovation.
The French HealthTech ecosystem comprises approximately 2,800 innovative companies, primarily in biotechnology, medical devices, and digital health/AI. Despite a global slowdown in private financing and a complex regulatory environment, the sector maintains its momentum. The average age of companies is 10 years, with 29 employees on average. R&D is a core pillar, with 64% of total expenditures dedicated to it. The industry has seen significant refinancing operations on stock markets, providing positive visibility. However, the sector faces challenges, including decreased average revenue and R&D investment. Strengthening financing conditions and regulatory simplification are essential for the sector's continued growth.
This content was automatically generated and/or translated by AI. It may contain inaccuracies. Please refer to the original sources for verification.